Ertugliflozin (PF 04971729)
CAS:
Ref. 3D-FE137670
100mg
228.00€
250mg
426.00€
500mg
568.00€
1g
906.00€
2g
1,515.00€
Product Information
Name:Ertugliflozin (PF 04971729)
Brand:Biosynth
Description:
Ertugliflozin is a novel, selective, and potent inhibitor of SGLT2. It is being developed for the treatment of type 2 diabetes and associated conditions such as hypertension, dyslipidemia and cardiovascular complications. Ertugliflozin selectively inhibits the renal glucose transporter SGLT2 to reduce urinary glucose excretion. In clinical trials ertugliflozin has been shown to significantly lower HbA1c levels in patients with type 2 diabetes mellitus. The drug was well tolerated in clinical trials with no clinically relevant adverse events observed. This agent has also been shown to decrease blood pressure in patients with type 2 diabetes mellitus and normotensive subjects.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:436.88 g/mol
Formula:C22H25ClO7
Purity:Min. 96 Area-%
Color/Form:White Off-White Powder
Technical inquiry about: Ertugliflozin (PF 04971729)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please add the desired products to your cart and manage the request from there. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.